You can buy or sell ANIX and other stocks, options, ETFs, and crypto commission-free!
Anixa Biosciences, Inc. Common Stock, also called Anixa Biosciences, is a cancer-focused biotechnology company, which focuses on harnessing the body's immune system in the fight against cancer. Read More It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
San Jose, California
52 Week High
52 Week Low
22nd Century Group